SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
即时热点
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
白昼流星
Lv3
1
232 积分
2023-05-23 加入
最近求助
最近应助
互助留言
Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy
24分钟前
已完结
Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy
28分钟前
已关闭
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms
45分钟前
已完结
Chatbots in science: What can ChatGPT do for you?
15天前
已完结
TP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclax
15天前
已完结
Microenvironment Matters: In Vitro 3D Bone Marrow Niches Differentially Modulate Survival, Phenotype and Drug Responses of Acute Myeloid Leukemia (AML) Cells
1个月前
已完结
Reversal of T-cell exhaustion: Mechanisms and synergistic approaches
1个月前
已完结
Multidimensional study of the heterogeneity of leukemia cells in t(8;21) acute myelogenous leukemia identifies the subtype with poor outcome
1个月前
已完结
Single-cell RNA-seq reveals novel immune-associated biomarkers for predicting prognosis in AML patients with RUNX1::RUNX1T1
1个月前
已完结
Williams–Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO
1个月前
已完结
没有进行任何应助
感谢,点赞
22分钟前
感谢,点赞,速度真快,帮大忙了
32分钟前
感谢,点赞,速度真快,帮大忙了
15天前
感谢,点赞,速度真快,帮大忙了
15天前
感谢,点赞,速度真快,帮大忙了
1个月前
感谢,点赞,速度真快,帮大忙了
1个月前
感谢,点赞,速度真快
1个月前
感谢,点赞,速度真快,帮大忙了
1个月前
感谢,点赞,速度真快,帮大忙了
1个月前
感谢,点赞,速度真快
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论